Cardiovascular Systems, Inc. – NASDAQ:CSII

Financial Health
0
1
2
3
4
5
6
7
8
9

Cardiovascular Systems stock price monthly change

+0.70%
month

Cardiovascular Systems stock price quarterly change

+49.48%
quarter

Cardiovascular Systems stock price yearly change

+0.15%
year

Cardiovascular Systems key metrics

Market Cap
843.96M
Enterprise value
N/A
P/E
-20.7
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
4.41
Price/Book
3292.19
PEG ratio
0.12
EPS
-0.95
Revenue
236.22M
EBITDA
-32.46M
Income
-36.93M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-16.8%
Oper. margin
-16.84%
Gross margin
73.23%
EBIT margin
-16.84%
EBITDA margin
-13.74%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cardiovascular Systems stock price history

Cardiovascular Systems stock forecast

Cardiovascular Systems financial statements

Cardiovascular Systems, Inc. (NASDAQ:CSII): Profit margin
Sep 2021 58.37M -8.61M -14.76%
Dec 2021 59.13M -8.96M -15.16%
Mar 2022 56.22M -9.65M -17.18%
Jun 2022 62.49M -9.69M -15.5%
Cardiovascular Systems, Inc. (NASDAQ:CSII): Debt to assets
Mar 2022 323991000 70.49M 21.76%
Jun 2022 322677000 73.19M 22.68%
Sep 2022 312038000 69.88M 22.4%
Dec 2022 311506000 72.11M 23.15%
Cardiovascular Systems, Inc. (NASDAQ:CSII): Cash Flow
Sep 2021 -10.78M 11.60M -5.02M
Dec 2021 -1.53M -497K 1.02M
Mar 2022 -2.12M 3.37M -159K
Jun 2022 -9.82M 7.67M 1.62M

Cardiovascular Systems alternative data

Cardiovascular Systems, Inc. (NASDAQ:CSII): Employee count
Aug 2023 725
Sep 2023 725
Oct 2023 725
Nov 2023 725
Dec 2023 725
Jan 2024 725
Feb 2024 725
Mar 2024 725
Apr 2024 725
May 2024 725
Jun 2024 725
Jul 2024 725

Cardiovascular Systems other data

54.20% -38.45%
of CSII is owned by hedge funds
21.49M -15.19M
shares is hold by hedge funds

Cardiovascular Systems, Inc. (NASDAQ:CSII): Insider trades (number of shares)
Period Buy Sel
Feb 2022 9067 0
May 2022 6000 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
ARONSON MARTHA GOLDBERG director
Restricted Stock Units 2,411 N/A N/A
Option
ARONSON MARTHA GOLDBERG director
Common Stock 2,411 N/A N/A
Purchase
POINTS JEFFREY S. officer: Chief Fi.. Common Stock 3,000 $14.5 $43,497
Purchase
WARD SCOTT R. director, officer: Chairman and..
Common Stock 3,000 $14.49 $43,467
Purchase
PAULSEN ERIK director
Common Stock 500 $19.05 $9,523
Purchase
POINTS JEFFREY S. officer: Chief Fi.. Common Stock 2,000 $18.2 $36,400
Purchase
ARONSON MARTHA GOLDBERG director
Common Stock 2,500 $18.43 $46,075
Purchase
ROBB RHONDA J. officer: Chief Op.. Common Stock 1,567 $18.72 $29,326
Purchase
WARD SCOTT R. director, officer: Chairman and..
Common Stock 2,500 $18.52 $46,293
Purchase
POINTS JEFFREY S. officer: Chief Fi.. Common Stock 1,000 $34.2 $34,200
Patent
Grant
Filling date: 10 Jun 2020 Issue date: 13 Sep 2022
Grant
Filling date: 20 Aug 2019 Issue date: 13 Sep 2022
Grant
Filling date: 19 Jun 2019 Issue date: 13 Sep 2022
Application
Filling date: 24 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 11 Jan 2022 Issue date: 8 Sep 2022
Grant
Filling date: 25 Mar 2019 Issue date: 6 Sep 2022
Application
Filling date: 19 May 2022 Issue date: 1 Sep 2022
Grant
Filling date: 30 Oct 2019 Issue date: 30 Aug 2022
Application
Filling date: 24 Feb 2022 Issue date: 25 Aug 2022
Application
Filling date: 25 Apr 2022 Issue date: 11 Aug 2022
Insider Compensation
Mr. Scott Raymond Ward B.Sc., M.S., MS (1960) Chairman, Pres & Chief Executive Officer
$1,460,000
Ms. Rhonda J. Robb (1968) Chief Operating Officer $954,830
Mr. Jeffrey S. Points (1977) Chief Financial Officer $682,690
Mr. Alexander Rosenstein (1972) Gen. Counsel & Corporation Sec. $614,960
Dr. Ryan D. Egeland M.D., Ph.D. (1975) Chief Medical Officer $522,930
Tuesday, 25 April 2023
prnewswire.com
Wednesday, 5 April 2023
Zacks Investment Research
Monday, 20 March 2023
Zacks Investment Research
Wednesday, 15 February 2023
Seeking Alpha
Friday, 10 February 2023
Pulse2
Zacks Investment Research
Thursday, 9 February 2023
The Motley Fool
InvestorPlace
Market Watch
Wednesday, 8 February 2023
Zacks Investment Research
Thursday, 19 January 2023
Zacks Investment Research
Friday, 11 November 2022
Zacks Investment Research
Saturday, 5 November 2022
Seeking Alpha
Thursday, 3 November 2022
Zacks Investment Research
Wednesday, 12 October 2022
Business Wire
Thursday, 1 September 2022
Zacks Investment Research
Wednesday, 20 July 2022
GuruFocus
Wednesday, 13 July 2022
Business Wire
Sunday, 8 May 2022
Seeking Alpha
Thursday, 5 May 2022
Zacks Investment Research
Wednesday, 4 May 2022
Zacks Investment Research
Monday, 25 April 2022
Zacks Investment Research
Wednesday, 13 April 2022
Zacks Investment Research
Business Wire
Monday, 14 March 2022
Zacks Investment Research
Thursday, 10 March 2022
Zacks Investment Research
Friday, 25 February 2022
InvestorPlace
Friday, 4 February 2022
Zacks Investment Research
Thursday, 3 February 2022
Seeking Alpha
Zacks Investment Research
  • When is Cardiovascular Systems's next earnings date?

    Unfortunately, Cardiovascular Systems's (CSII) next earnings date is currently unknown.

  • Does Cardiovascular Systems pay dividends?

    No, Cardiovascular Systems does not pay dividends.

  • How much money does Cardiovascular Systems make?

    Cardiovascular Systems has a market capitalization of 843.96M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.79% to 236.22M US dollars.

  • What is Cardiovascular Systems's stock symbol?

    Cardiovascular Systems, Inc. is traded on the NASDAQ under the ticker symbol "CSII".

  • What is Cardiovascular Systems's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Cardiovascular Systems?

    Shares of Cardiovascular Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Cardiovascular Systems's key executives?

    Cardiovascular Systems's management team includes the following people:

    • Mr. Scott Raymond Ward B.Sc., M.S., MS Chairman, Pres & Chief Executive Officer(age: 65, pay: $1,460,000)
    • Ms. Rhonda J. Robb Chief Operating Officer(age: 57, pay: $954,830)
    • Mr. Jeffrey S. Points Chief Financial Officer(age: 48, pay: $682,690)
    • Mr. Alexander Rosenstein Gen. Counsel & Corporation Sec.(age: 53, pay: $614,960)
    • Dr. Ryan D. Egeland M.D., Ph.D. Chief Medical Officer(age: 50, pay: $522,930)
  • How many employees does Cardiovascular Systems have?

    As Jul 2024, Cardiovascular Systems employs 725 workers.

  • When Cardiovascular Systems went public?

    Cardiovascular Systems, Inc. is publicly traded company for more then 19 years since IPO on 28 Jun 2006.

  • What is Cardiovascular Systems's official website?

    The official website for Cardiovascular Systems is csi360.com.

  • Where are Cardiovascular Systems's headquarters?

    Cardiovascular Systems is headquartered at 1225 Old Highway 8 Northwest, Saint Paul, MN.

  • How can i contact Cardiovascular Systems?

    Cardiovascular Systems's mailing address is 1225 Old Highway 8 Northwest, Saint Paul, MN and company can be reached via phone at +65 12591600.

Cardiovascular Systems company profile:

Cardiovascular Systems, Inc.

csi360.com
Exchange:

NASDAQ

Full time employees:

725

Industry:

Medical - Devices

Sector:

Healthcare

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

1225 Old Highway 8 Northwest
Saint Paul, MN 55112-6416

CIK: 0001180145
ISIN: US1416191062
CUSIP: 141619106